NURS6521 ADVANCED PHARMACOLOGY MIDTERM EXAM
PRACTICE QUESTIONS FOR ACTUAL EXAMS AND 100% CORRECT
ANSWERS VERIFIED | FULL EXAM PREP TESTBANK | INSTANT PDF
DOWNLOAD | GUARANTEED PASS
CORE DOMAINS:
Pharmacokinetics and Pharmacodynamics
Pharmacotherapeutics across the Lifespan
Neurological and Neuromuscular Pharmacology
Cardiovascular and Renal Pharmacology
Respiratory and Endocrine Pharmacology
Gastrointestinal and Hematologic Pharmacology
Antimicrobial and Immunopharmacology
Drug Safety, Regulation, and Prescription Writing
This comprehensive midterm exam test bank is designed for advanced practice
nursing students. It integrates complex physiological principles with
pharmacological interventions, focusing on clinical decision-making, drug-
receptor interactions, and the management of diverse patient populations in
primary and acute care settings.
SECTION 1: Questions
1. A patient with chronic renal failure requires a medication that is primarily excreted
by the kidneys. Which pharmacokinetic process is most significantly altered?
, ANS: Excretion
2. Which regulatory body is responsible for the final approval of new drug
applications in the United States?
ANS: The Food and Drug Administration (FDA)
3. An elderly patient is prescribed a lipophilic medication. How does the increased
body fat percentage in geriatric patients typically affect the volume of distribution
for this drug?
ANS: Increased volume of distribution
4. A patient is taking a drug that is a known CYP3A4 inhibitor. If they begin taking a
second drug that is a substrate of the same enzyme, what is the likely effect on the
second drug’s serum levels?
ANS: Increased serum levels and potential toxicity
5. Which schedule of controlled substances has the highest potential for abuse while
still maintaining an accepted medical use?
ANS: Schedule II
6. A pregnant patient in her third trimester requires an antibiotic. Which
physiological change in pregnancy increases the required dose of a hydrophilic
drug?
ANS: Increased plasma volume and glomerular filtration rate
, 7. What is the primary mechanism of action of thiazide diuretics in the treatment of
hypertension?
ANS: Inhibition of the sodium-chloride symporter in the distal convoluted tubule
8. A patient on warfarin therapy starts taking amiodarone. What adjustment is
typically required for the warfarin dose?
ANS: Decrease the warfarin dose
9. Which protein is the primary binder for acidic drugs in the plasma?
ANS: Albumin
10.A pediatric patient’s weight-based dose is calculated at 12.5 mg/kg. If the child
weighs 20 kg and the concentration is 50 mg/5 mL, how many milliliters should be
administered?
ANS: 25 mL
11.What is the antidote for a patient experiencing a cholinergic crisis due to
organophosphate poisoning?
ANS: Atropine
12.In a "first-pass effect," where does the initial metabolism of an orally administered
drug occur?
ANS: The liver
13.A patient with heart failure is prescribed Digoxin. What electrolyte imbalance most
significantly increases the risk of Digoxin toxicity?
PRACTICE QUESTIONS FOR ACTUAL EXAMS AND 100% CORRECT
ANSWERS VERIFIED | FULL EXAM PREP TESTBANK | INSTANT PDF
DOWNLOAD | GUARANTEED PASS
CORE DOMAINS:
Pharmacokinetics and Pharmacodynamics
Pharmacotherapeutics across the Lifespan
Neurological and Neuromuscular Pharmacology
Cardiovascular and Renal Pharmacology
Respiratory and Endocrine Pharmacology
Gastrointestinal and Hematologic Pharmacology
Antimicrobial and Immunopharmacology
Drug Safety, Regulation, and Prescription Writing
This comprehensive midterm exam test bank is designed for advanced practice
nursing students. It integrates complex physiological principles with
pharmacological interventions, focusing on clinical decision-making, drug-
receptor interactions, and the management of diverse patient populations in
primary and acute care settings.
SECTION 1: Questions
1. A patient with chronic renal failure requires a medication that is primarily excreted
by the kidneys. Which pharmacokinetic process is most significantly altered?
, ANS: Excretion
2. Which regulatory body is responsible for the final approval of new drug
applications in the United States?
ANS: The Food and Drug Administration (FDA)
3. An elderly patient is prescribed a lipophilic medication. How does the increased
body fat percentage in geriatric patients typically affect the volume of distribution
for this drug?
ANS: Increased volume of distribution
4. A patient is taking a drug that is a known CYP3A4 inhibitor. If they begin taking a
second drug that is a substrate of the same enzyme, what is the likely effect on the
second drug’s serum levels?
ANS: Increased serum levels and potential toxicity
5. Which schedule of controlled substances has the highest potential for abuse while
still maintaining an accepted medical use?
ANS: Schedule II
6. A pregnant patient in her third trimester requires an antibiotic. Which
physiological change in pregnancy increases the required dose of a hydrophilic
drug?
ANS: Increased plasma volume and glomerular filtration rate
, 7. What is the primary mechanism of action of thiazide diuretics in the treatment of
hypertension?
ANS: Inhibition of the sodium-chloride symporter in the distal convoluted tubule
8. A patient on warfarin therapy starts taking amiodarone. What adjustment is
typically required for the warfarin dose?
ANS: Decrease the warfarin dose
9. Which protein is the primary binder for acidic drugs in the plasma?
ANS: Albumin
10.A pediatric patient’s weight-based dose is calculated at 12.5 mg/kg. If the child
weighs 20 kg and the concentration is 50 mg/5 mL, how many milliliters should be
administered?
ANS: 25 mL
11.What is the antidote for a patient experiencing a cholinergic crisis due to
organophosphate poisoning?
ANS: Atropine
12.In a "first-pass effect," where does the initial metabolism of an orally administered
drug occur?
ANS: The liver
13.A patient with heart failure is prescribed Digoxin. What electrolyte imbalance most
significantly increases the risk of Digoxin toxicity?
